RepliCel

RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia.[1] The company focuses on development of cell therapies using a patient's own cells (autologous cell therapy).[1] The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly,[3] and hair restoration.[2] The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.[1]

RepliCel Life Sciences Inc.
Founder
  • Rolf Hoffmann
  • Kevin McElwee
Headquarters
Vancouver, British Columbia
,
Canada
Key people
  • David Hall (CEO)
Number of employees
15 FTE (2015)
Websitewww.replicel.com
Footnotes / references
[1][2]

The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company.[2] An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them.[1]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.